Detalhe da pesquisa
1.
CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis.
Int J Mol Sci
; 25(4)2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396995
2.
Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results.
BMC Cancer
; 20(1): 1164, 2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33246428
3.
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study.
Oncologist
; 24(1): 38-46, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794066
4.
Development of morphea during Nivolumab treatment.
Australas J Dermatol
; 63(2): 269-271, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325471
5.
COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
J Am Acad Dermatol
; 84(5): 1412-1415, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581187
6.
Clinico-pathological factors related to metastatic pathway in localised melanoma.
Australas J Dermatol
; 62(4): 518-521, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637528
7.
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.
BMC Cancer
; 15: 60, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886378
8.
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
BMC Cancer
; 15: 495, 2015 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26138480
9.
Appendiceal mixed adenoneuroendocrine carcinomas, a rare entity that can present as a Krukenberg tumor: case report and review of the literature.
World J Surg Oncol
; 13: 325, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26612593
10.
Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center's decade of experience.
Front Oncol
; 14: 1322116, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450188
11.
Consensus on relevant psychosocial interventions applied in health institutions to prevent psychological violence at work: Delphi method.
BMC Res Notes
; 17(1): 19, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183078
12.
Access to melanoma drugs in Spain: a cross-sectional survey.
Clin Transl Oncol
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750345
13.
Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?
Pharmaceutics
; 15(3)2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986683
14.
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.
Clin Cancer Res
; 29(2): 379-388, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074154
15.
Analysis of Costs Associated with the Use of Personalized Automated Dosing Systems versus Manual Preparation in a Residential Center for the Elderly in Extremadura.
Healthcare (Basel)
; 11(4)2023 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36833154
16.
Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going.
Clin Colorectal Cancer
; 21(2): 71-79, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277355
17.
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial.
Eur J Cancer
; 145: 158-167, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485079
18.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782108
19.
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines.
Mol Cancer Ther
; 8(4): 771-8, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19372549
20.
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer.
Mol Cancer Ther
; 8(1): 194-202, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19139129